IP Library Granted Patent US 11,083,858
Granted Patent B2
US 11,083,858 · App. 16/285,694 · Granted Aug 10, 2021

Nasal delivery devices

Inventors: Per Gisle Djupesland (Oslo, NO); Colin David Sheldrake (Wiltshire, GB)
Assignee: OptiNose AS
A61M15/08A61M11/006A61M11/007A61M11/02A61M15/002A61M15/0003A61M15/009A61M15/0015A61M15/0021A61M15/0098A61M11/08A61M15/0095A61M2202/0468A61M2202/064A61M2205/8281
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,083,858
App. No.
16/285,694
Granted
Aug 10, 2021
Kind
B2
Abstract

A nasal delivery device for and a method of delivering substance to a nasal airway of a subject, the nasal delivery device including a mouthpiece ( 519 ) through which the subject in use exhales to cause closure of the oropharyngeal velum of the subject; a nosepiece ( 517 ) for fitting to a nostril of a subject, the nosepiece including a nozzle ( 549 ) through which the substance is in use delivered to the nasal airway; and a manually-actuatable substance supply unit ( 520 ) for delivering substance through the nozzle of the nosepiece.

Claims (11)

1. A method of delivering substance to a nasal airway of a subject, comprising:

fitting a nosepiece of a delivery device to a nostril of the subject, the delivery device including a manually-actuatable substance supply unit for delivering the substance through a nozzle disposed within the nosepiece, and a flow regulator configured, with actuating movement of the substance supply unit, to regulate one or more flow characteristics of an exhalation air flow as delivered through the nosepiece, the flow regulator including an aperture into which extends a movable part of the substance supply unit, such that, with actuating movement of the substance supply unit, an effective area of a flow channel to the nosepiece has a predetermined profile over the actuating movement of the substance supply unit; and

manually actuating the substance supply unit to deliver the substance to the nasal airway of the subject, the exhalation air flow having the one or more regulated flow characteristics.

2. The method of claim 1 , wherein the nosepiece fitting comprises fitting the nosepiece to the nostril of the subject so that the nosepiece is in sealing engagement with the nostril of the subject.

3. The method of claim 1 , further comprising:

closing the oropharyngeal velum of the subject.

4. The method of claim 3 , wherein the delivery device further comprises a mouthpiece, and the oropharyngeal velum closing comprises the subject exhaling through the mouthpiece so as to close the oropharyngeal velum of the subject.

5. The method of claim 1 , wherein the delivery device further comprises a valve assembly fluidly connected to a mouthpiece and the nosepiece, and operable between a closed configuration in which there is no fluid communication path between the mouthpiece and the nosepiece and an open configuration on actuation of the substance supply unit, whereby the exhalation air flow is delivered through the nosepiece on actuation of the substance supply unit.

6. The method of claim 1 , wherein the one or more regulated flow characteristics comprise flow rate, flow profile and flow duration of the exhalation air flow.

7. The method of claim 1 , wherein the substance is a liquid.

8. The method of claim 1 , wherein the substance is oxytocin.

Assignments (8)
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT REEL/FRAME 71337/0132 Recorded Mar 17, 2026
From: OAKTREE FUND ADMINISTRATION, LLC
To: OPTINOSE, INC.
Reel/Frame 075101/0804 →
PATENT SECURITY AGREEMENT Recorded Mar 16, 2026
From: OPTINOSE, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 075111/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2025
From: DJUPESLAND, PER GISLE; SHELDRAKE, COLIN DAVID
To: OPTINOSE AS
Reel/Frame 072271/0147 →
SECURITY INTEREST Recorded May 22, 2025
From: OPTINOSE, INC.
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 071337/0132 →
RELEASE OF SECURITY INTEREST Recorded May 21, 2025
From: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
To: OPTINOSE INC.
Reel/Frame 071547/0979 →
CHANGE OF ADDRESS Recorded Jan 8, 2025
From: OPTINOSE, INC.
To: OPTINOSE, INC.
Reel/Frame 069848/0093 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2022
From: OPTINOSE AS
To: OPTINOSE INC
Reel/Frame 061546/0424 →
SECURITY INTEREST Recorded Sep 13, 2019
From: OPTINOSE AS
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 050371/0913 →